3Q26 tracking in line, FX and CPI benefits to come

Research evidence excerpt

3Q26 tracking in line, FX and CPI benefits to come

t fully paid ordinary weighted average number of

in 12 months Note: expected return is reflective of a Medium Volatility shares

Valuation – The company's estimated stock and should be assumed to adjust proportionately

All Reported numbers for Australian/NZ listed stocks are fair value share price based on the disclosed with volatility risk

modelled under IFRS (International Financial Reporting valuation methodology

Standards). Note: Quant recommendations may differ

from Fundamental Analyst recommendations

Recommendation proportions for quarter ending 31 Mar 2026

AU/NZ Asia USA

Outperform 66.90% 69.32% 67.14% (for global coverage by Macquarie, 1.93% of stocks followed are investment banking clients)

Neutral 27.18% 17.21% 32.86% (for global coverage by Macquarie, 0.40% of stocks followed are investment banking clients)

Underperform 5.92% 13.47% 0.00% (for global coverage by Macquarie, 0.00% of stocks followed are investment banking clients)

Company-Specific Disclosures

Company Name Disclosure

Vital Healthcare Property A Macquarie analyst(s) involved with the preparation of this research has, in the past 12 months, visited material operations of

Trust (VHP NZ) Vital Healthcare Property Trust. In connection with such a visit, the company may have furnished local transportation and/or

Neutral accommodation, which requires authorisation in adherence with Macquarie policy requirements.

12-month target: NZD2.05 - DCF/NTA

Valuation: NZD 2.00 - DCF (WACC 6.9%,

beta 0.8, ERP 7.0%, RFR 4.4%, TGR 2.0%)

Price: NZD1.83

Target Price Risk Disclosures

Company Name Risk Disclosure

Trajectory of interest rates and FX impacting asset values and earnings. Vital Healthcare Property • Trust (VHP NZ)